Research study Program year 2020 Source: CMS Open Payments

Nn9747-4261

Research payments

$1,527,139

41 payments

Through program year 2020, $1,527,139 in research payments was reported against Nn9747-4261, across 41 payments, paid by Novo Nordisk AS.

Paid by
Novo Nordisk AS
ClinicalTrials.gov
No trial number was reported for this study

By program year

2 rows
Year Kind Amount Payments
2020 Research $290 1
2019 Research $1,526,849 40

Breakdown

Who paid Research payments · program years 2019–2020
  1. Novo Nordisk AS $1,527,139 41 payments
Who received the money Research payments · program years 2019–2020
  1. Celerion Organisation paid for research $950,556 28 payments
  2. Celerion, Inc Organisation paid for research $576,583 13 payments

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

2 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record